Law firm Kirby McInerney is investigating SLNO for securities law violations. A report claimed Vykat XR is overpriced and unsafe impacting SLNO share prices. Discontinuation rate for Vykat XR was 8% due to adverse effects revealed in earnings call. SLNO shares fell significantly after negative reports and earnings disclosures. Investors with information should contact the law firm regarding their rights.
Comments on Vykat XR's safety and pricing have led to significant share declines historically.
Immediate legal concerns might affect stock performance, given recent sharp declines post-report.
Ongoing investigations and negative findings about products can severely impact SLNO's market perception.